Clinical Significance of<i>HRNR</i>Expression in Patients With Stage II/III Gastric Cancer After Curative Gastrectomy
In patients with pStage II/III GC after curative gastrectomy, HRNR expression in GC tissue may be a useful prognostic marker.
Authors
- Shinsuke Nagasawa (ORCID: https://orcid.org/0000-0001-7773-9258)
- Yayoi Kimura
- KYOHEI KANEMATSU (ORCID: https://orcid.org/0000-0002-0963-8890)
- Toru Aoyama
- ITARU HASHIMOTO (ORCID: https://orcid.org/0000-0002-8398-1494)
- Takanobu Yamada (ORCID: https://orcid.org/0000-0003-3564-6891)
- Yohei Miyagi (ORCID: https://orcid.org/0000-0002-0056-7010)
- Takashi Oshima (ORCID: https://orcid.org/0000-0001-5818-8649)
- Takashi Ogata (ORCID: https://orcid.org/0000-0002-6453-6408)
- Yuta Nakayama
- MIE TANABE
- Yukihiko Hiroshima (ORCID: https://orcid.org/0009-0005-7384-3513)
Institutions
- Yokohama City University Medical Center (JP)
- Kanagawa Prefectural Hospital Organization (JP)
- Kanagawa Cancer Center
- Yokohama City University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-09-30
- DOI
- https://doi.org/10.21873/anticanres.17287
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.42